Given the importance of amylin in glucose regulation, its pronounced tendency to aggregate and cause islet dysfunction in T2DM [3], and given emerging evidence that it forms deposits in the brain in Alzheimer’s disease [4,5], there is a great need to better understand the factors regulating amylin proteostasis. This evidence concerns the gene IAPP and type 2 diabetes mellitus.